dacarbazine,doxorubicin,brentuximab vedotin,vinblastine,bleomycin,vincristine
seagen
[]
#hd21 shows non-inferiority of 4-6 pet-adapted cycles of brecadd vs ebeacopp in advanced-stage hl. brecadd becomes new soc w a 3-year pfs of 94.9% and (importantly!) less toxicity. great international collaborative academic effort led by #ghsg #17icml #icml2023 
Physician Scientist @UKKoeln & @MPIAGE. Hemato-Oncology, Lymphoma, Immunotherapy. Views are mine & no advise, RT/like no endorsement. COI: https://t.co/lOCrBZDrQP